Hemoglobin raffimer

N/A

Report date: 2022/11/25 17:01:16

Base Information

Drug NameHemoglobin raffimer

Drug Alias NameHaemoglobin raffimerHuman hemoglobinHuman haemoglobinHemolink

ClassificationBiologics > Blood components

Mechanisms of ActionOxygen carriers

TargetsNot applicable

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesHemosol Corp

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

ATC CodeB05AA09